Skip to main content

Table 1 Comparison of embryonic, adult, and iPSCs for generating organoids

From: From gut to liver: organoids as platforms for next-generation toxicology assessment vehicles for xenobiotics

Feature

ESCs

ASCs

iPSCs

References

Origin

Inner cell mass of a blastocyst (early embryo)

Various adult tissues (bone marrow, fat, etc.)

Reprogrammed adult cells

[32]

Pluripotency

Yes—Can differentiate into all three germ layers (endoderm, mesoderm, ectoderm) and become any cell type in the body

No (Multipotent)—Can differentiate into a limited number of cell types specific to their tissue of origin

Yes (Similar to embryonic)—Can potentially differentiate into all three germ layers

[33, 34]

Self-renewal

Yes—Can divide indefinitely while remaining undifferentiated

Yes (Limited)—Can divide for many cycles but eventually lose ability to self-renew

Yes—Can divide for extended periods

[35, 36]

Ethical Concerns

Yes—Destroys a blastocyst, raising ethical questions

No—No embryos harmed

Can vary—Depends on the method used for reprogramming

[29, 37]

Availability

Limited—Requires strict regulations and may not be readily available

More readily available—Can be isolated from various tissues

Potentially more readily available than embryonic

[38]

Immune Rejection

High risk—Cells are not genetically identical to the recipient

Lower risk—Can be obtained from the same patient (autologous)

Similar to embryonic (depends on reprogramming method)

[39, 40]